Samsung Biologics Q1 Operating Profit 74.3 Billion KRW... 18.7% Increase YoY
[Asia Economy Reporter Yoo Byung-don] Samsung Biologics announced on the 28th that its consolidated operating profit for the first quarter of this year was tentatively estimated at 74.3 billion KRW, an increase of 18.73% compared to the same period last year.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- U.S. Treasury Secretary: "30-Day Temporary License for Russian Crude Oil Transactions"
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
Sales amounted to 260.8 billion KRW, up 25.87% from the same period last year. Net profit increased by 66.36% to 61 billion KRW.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
